procedure
The Food and Drug Administration (FDA) utilizes three primary pathways for approving Software as a Medical Device (SaMD): (1) Premarket Approval (PMA) for high-risk devices; (2) De Novo classification for novel moderate-risk devices; and (3) 510(k) clearance for moderate to low-risk devices that are substantially equivalent to existing approved devices.

Authors

Sources

Referenced by nodes (1)